Reilmann Ralf, Leavitt Blair R, Ross Christopher A
George-Huntington-Institute, Technology-Park, Muenster, Germany; Department of Neurodegenerative Diseases and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.
Mov Disord. 2014 Sep 15;29(11):1335-41. doi: 10.1002/mds.26011. Epub 2014 Aug 27.
Huntington's disease (HD) is currently diagnosed based on the presence of motor signs indicating 99% "diagnostic confidence" for HD. Recent advances in the understanding of HD natural history and neurobiology indicate that disease-related brain changes begin at least 12 to 15 years before the formal diagnosis based on motor onset. Furthermore, subtle motor dysfunction, cognitive changes, and behavioral alterations are often seen before diagnosis made according to the current criteria. As disease-modifying treatments are developed, likely beginning therapy early will be desirable. We therefore suggest that expanded diagnostic criteria for HD should be adapted to better reflect the natural history of the disease, to enable the conduct of clinical trials in premanifest subjects targeting prevention of neurodegeneration, and to facilitate earlier symptomatic treatment. We propose a new set of criteria for HD diagnostic categories in the International Classification of Diseases that reflect our current understanding of HD natural history and pathogenesis. Based on defined criteria, for example, the Diagnostic Confidence Level and the Total Functional Capacity scales of the Unified Huntington's Disease Rating Scale, HD should be divided in the categories "genetically confirmed" with the subcategories "presymptomatic," "prodromal," and "manifest" and "not genetically confirmed" subdivided into "clinically at risk," "clinically prodromal," and "clinically manifest."
亨廷顿舞蹈症(HD)目前是根据存在表明对HD有99%“诊断置信度”的运动体征来诊断的。对HD自然史和神经生物学认识的最新进展表明,与疾病相关的脑部变化在基于运动发作的正式诊断前至少12至15年就已开始。此外,在根据当前标准做出诊断之前,常常会出现细微的运动功能障碍、认知变化和行为改变。随着疾病修饰治疗方法的研发,尽早开始治疗可能是可取的。因此,我们建议应采用扩展的HD诊断标准,以更好地反映疾病的自然史,从而能够在临床前期受试者中开展针对预防神经退行性变的临床试验,并促进更早的症状性治疗。我们提出了一套新的HD诊断类别标准,用于《国际疾病分类》,以反映我们目前对HD自然史和发病机制的理解。例如,根据既定标准,即统一亨廷顿舞蹈症评定量表的诊断置信度水平和总功能能力量表,HD应分为“基因确诊”类别,其亚类别为“临床前期”、“前驱期”和“显性期”,以及“未基因确诊”类别,细分为“临床风险期”、“临床前驱期”和“临床显性期”。